Efficacy of Dexmedetomidine on Postoperative Analgesia
Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
This prospective, randomized, double-blind study is designed to evaluate the postoperative
analgesic efficacy of dexmedetomidine as an adjunct to ropivacaine in erector spinae block in
patients undergoing radical mastectomy. The investigators hypothesis is that the
administration of ropivacaine 0.5% associated with dexmedetomidine in the blockade via the
plane in the erector spinae is less effective in controlling acute postoperative pain in
radical mastectomy than the administration of ropivacaine 0.5% without dexmedetomidine.